Global Paclitaxel Drug-Eluting Balloon Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Paclitaxel Drug-Eluting Balloon market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Paclitaxel Drug-Eluting Balloon players cover Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic and Philips, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
LPI (LP Information)' newest research report, the “Paclitaxel Drug-Eluting Balloon Industry Forecast” looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2022, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2023 through 2029. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Paclitaxel Drug-Eluting Balloon market?
What factors are driving Paclitaxel Drug-Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel Drug-Eluting Balloon market opportunities vary by end market size?
How does Paclitaxel Drug-Eluting Balloon break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Paclitaxel Drug-Eluting Balloon market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Paclitaxel Drug-Eluting Balloon is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Paclitaxel Drug-Eluting Balloon players cover Medtronic, Boston Scientific, B. Braun, Cook Medical, Cardionovum, Aachen Resonance, QT Vascular, Biotronic and Philips, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
LPI (LP Information)' newest research report, the “Paclitaxel Drug-Eluting Balloon Industry Forecast” looks at past sales and reviews total world Paclitaxel Drug-Eluting Balloon sales in 2022, providing a comprehensive analysis by region and market sector of projected Paclitaxel Drug-Eluting Balloon sales for 2023 through 2029. With Paclitaxel Drug-Eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel Drug-Eluting Balloon industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel Drug-Eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel Drug-Eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Paclitaxel Drug-Eluting Balloon market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel Drug-Eluting Balloon and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel Drug-Eluting Balloon.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel Drug-Eluting Balloon market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Balloon-Only Coating
- Drug-Coated Balloon
- Peripheral Artery Disease
- Coronary Artery Disease
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- B. Braun
- Cook Medical
- Cardionovum
- Aachen Resonance
- QT Vascular
- Biotronic
- Philips
- Eurocor
- Yinyi Biotech
- Lepu Medical Technology
What is the 10-year outlook for the global Paclitaxel Drug-Eluting Balloon market?
What factors are driving Paclitaxel Drug-Eluting Balloon market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel Drug-Eluting Balloon market opportunities vary by end market size?
How does Paclitaxel Drug-Eluting Balloon break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Country/Region, 2018, 2022 & 2029
2.2 Paclitaxel Drug-Eluting Balloon Segment by Type
2.2.1 Balloon-Only Coating
2.2.2 Drug-Coated Balloon
2.3 Paclitaxel Drug-Eluting Balloon Sales by Type
2.3.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
2.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Type (2018-2023)
2.3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2018-2023)
2.4 Paclitaxel Drug-Eluting Balloon Segment by Application
2.4.1 Peripheral Artery Disease
2.4.2 Coronary Artery Disease
2.5 Paclitaxel Drug-Eluting Balloon Sales by Application
2.5.1 Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2018-2023)
2.5.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Application (2018-2023)
2.5.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2018-2023)
3 GLOBAL PACLITAXEL DRUG-ELUTING BALLOON BY COMPANY
3.1 Global Paclitaxel Drug-Eluting Balloon Breakdown Data by Company
3.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Company (2018-2023)
3.1.2 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2018-2023)
3.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Company (2018-2023)
3.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2018-2023)
3.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2018-2023)
3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Drug-Eluting Balloon Product Location Distribution
3.4.2 Players Paclitaxel Drug-Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Geographic Region (2018-2023)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Country/Region (2018-2023)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Country/Region (2018-2023)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Country/Region (2018-2023)
4.3 Americas Paclitaxel Drug-Eluting Balloon Sales Growth
4.4 APAC Paclitaxel Drug-Eluting Balloon Sales Growth
4.5 Europe Paclitaxel Drug-Eluting Balloon Sales Growth
4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country
5.1.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
5.1.2 Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
5.2 Americas Paclitaxel Drug-Eluting Balloon Sales by Type
5.3 Americas Paclitaxel Drug-Eluting Balloon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region
6.1.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2018-2023)
6.1.2 APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2018-2023)
6.2 APAC Paclitaxel Drug-Eluting Balloon Sales by Type
6.3 APAC Paclitaxel Drug-Eluting Balloon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel Drug-Eluting Balloon by Country
7.1.1 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
7.1.2 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
7.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Type
7.3 Europe Paclitaxel Drug-Eluting Balloon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon by Country
8.1.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
8.1.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
8.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type
8.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon
10.3 Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
10.4 Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Drug-Eluting Balloon Distributors
11.3 Paclitaxel Drug-Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Drug-Eluting Balloon Market Size Forecast by Region
12.1.1 Global Paclitaxel Drug-Eluting Balloon Forecast by Region (2024-2029)
12.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paclitaxel Drug-Eluting Balloon Forecast by Type
12.7 Global Paclitaxel Drug-Eluting Balloon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Cook Medical
13.4.1 Cook Medical Company Information
13.4.2 Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cook Medical Main Business Overview
13.4.5 Cook Medical Latest Developments
13.5 Cardionovum
13.5.1 Cardionovum Company Information
13.5.2 Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cardionovum Main Business Overview
13.5.5 Cardionovum Latest Developments
13.6 Aachen Resonance
13.6.1 Aachen Resonance Company Information
13.6.2 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aachen Resonance Main Business Overview
13.6.5 Aachen Resonance Latest Developments
13.7 QT Vascular
13.7.1 QT Vascular Company Information
13.7.2 QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 QT Vascular Main Business Overview
13.7.5 QT Vascular Latest Developments
13.8 Biotronic
13.8.1 Biotronic Company Information
13.8.2 Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biotronic Main Business Overview
13.8.5 Biotronic Latest Developments
13.9 Philips
13.9.1 Philips Company Information
13.9.2 Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.9.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Philips Main Business Overview
13.9.5 Philips Latest Developments
13.10 Eurocor
13.10.1 Eurocor Company Information
13.10.2 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eurocor Main Business Overview
13.10.5 Eurocor Latest Developments
13.11 Yinyi Biotech
13.11.1 Yinyi Biotech Company Information
13.11.2 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yinyi Biotech Main Business Overview
13.11.5 Yinyi Biotech Latest Developments
13.12 Lepu Medical Technology
13.12.1 Lepu Medical Technology Company Information
13.12.2 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lepu Medical Technology Main Business Overview
13.12.5 Lepu Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Paclitaxel Drug-Eluting Balloon by Country/Region, 2018, 2022 & 2029
2.2 Paclitaxel Drug-Eluting Balloon Segment by Type
2.2.1 Balloon-Only Coating
2.2.2 Drug-Coated Balloon
2.3 Paclitaxel Drug-Eluting Balloon Sales by Type
2.3.1 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
2.3.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Type (2018-2023)
2.3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2018-2023)
2.4 Paclitaxel Drug-Eluting Balloon Segment by Application
2.4.1 Peripheral Artery Disease
2.4.2 Coronary Artery Disease
2.5 Paclitaxel Drug-Eluting Balloon Sales by Application
2.5.1 Global Paclitaxel Drug-Eluting Balloon Sale Market Share by Application (2018-2023)
2.5.2 Global Paclitaxel Drug-Eluting Balloon Revenue and Market Share by Application (2018-2023)
2.5.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2018-2023)
3 GLOBAL PACLITAXEL DRUG-ELUTING BALLOON BY COMPANY
3.1 Global Paclitaxel Drug-Eluting Balloon Breakdown Data by Company
3.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Company (2018-2023)
3.1.2 Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2018-2023)
3.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Company (2018-2023)
3.2.1 Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2018-2023)
3.2.2 Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2018-2023)
3.3 Global Paclitaxel Drug-Eluting Balloon Sale Price by Company
3.4 Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Drug-Eluting Balloon Product Location Distribution
3.4.2 Players Paclitaxel Drug-Eluting Balloon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Geographic Region (2018-2023)
4.1.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Paclitaxel Drug-Eluting Balloon Market Size by Country/Region (2018-2023)
4.2.1 Global Paclitaxel Drug-Eluting Balloon Annual Sales by Country/Region (2018-2023)
4.2.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue by Country/Region (2018-2023)
4.3 Americas Paclitaxel Drug-Eluting Balloon Sales Growth
4.4 APAC Paclitaxel Drug-Eluting Balloon Sales Growth
4.5 Europe Paclitaxel Drug-Eluting Balloon Sales Growth
4.6 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country
5.1.1 Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
5.1.2 Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
5.2 Americas Paclitaxel Drug-Eluting Balloon Sales by Type
5.3 Americas Paclitaxel Drug-Eluting Balloon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region
6.1.1 APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2018-2023)
6.1.2 APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2018-2023)
6.2 APAC Paclitaxel Drug-Eluting Balloon Sales by Type
6.3 APAC Paclitaxel Drug-Eluting Balloon Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel Drug-Eluting Balloon by Country
7.1.1 Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
7.1.2 Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
7.2 Europe Paclitaxel Drug-Eluting Balloon Sales by Type
7.3 Europe Paclitaxel Drug-Eluting Balloon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon by Country
8.1.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023)
8.1.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023)
8.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type
8.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon
10.3 Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
10.4 Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Drug-Eluting Balloon Distributors
11.3 Paclitaxel Drug-Eluting Balloon Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL DRUG-ELUTING BALLOON BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Drug-Eluting Balloon Market Size Forecast by Region
12.1.1 Global Paclitaxel Drug-Eluting Balloon Forecast by Region (2024-2029)
12.1.2 Global Paclitaxel Drug-Eluting Balloon Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paclitaxel Drug-Eluting Balloon Forecast by Type
12.7 Global Paclitaxel Drug-Eluting Balloon Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Cook Medical
13.4.1 Cook Medical Company Information
13.4.2 Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cook Medical Main Business Overview
13.4.5 Cook Medical Latest Developments
13.5 Cardionovum
13.5.1 Cardionovum Company Information
13.5.2 Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cardionovum Main Business Overview
13.5.5 Cardionovum Latest Developments
13.6 Aachen Resonance
13.6.1 Aachen Resonance Company Information
13.6.2 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aachen Resonance Main Business Overview
13.6.5 Aachen Resonance Latest Developments
13.7 QT Vascular
13.7.1 QT Vascular Company Information
13.7.2 QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 QT Vascular Main Business Overview
13.7.5 QT Vascular Latest Developments
13.8 Biotronic
13.8.1 Biotronic Company Information
13.8.2 Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biotronic Main Business Overview
13.8.5 Biotronic Latest Developments
13.9 Philips
13.9.1 Philips Company Information
13.9.2 Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.9.3 Philips Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Philips Main Business Overview
13.9.5 Philips Latest Developments
13.10 Eurocor
13.10.1 Eurocor Company Information
13.10.2 Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Eurocor Main Business Overview
13.10.5 Eurocor Latest Developments
13.11 Yinyi Biotech
13.11.1 Yinyi Biotech Company Information
13.11.2 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yinyi Biotech Main Business Overview
13.11.5 Yinyi Biotech Latest Developments
13.12 Lepu Medical Technology
13.12.1 Lepu Medical Technology Company Information
13.12.2 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
13.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lepu Medical Technology Main Business Overview
13.12.5 Lepu Medical Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Balloon-Only Coating
Table 4. Major Players of Drug-Coated Balloon
Table 5. Global Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 6. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2018-2023) & ($ million)
Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2018-2023)
Table 9. Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 11. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Table 12. Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2018-2023)
Table 13. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2018-2023)
Table 14. Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Paclitaxel Drug-Eluting Balloon Sales by Company (2018-2023) & (K Units)
Table 16. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2018-2023)
Table 17. Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2018-2023)
Table 19. Global Paclitaxel Drug-Eluting Balloon Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution and Sales Area
Table 21. Players Paclitaxel Drug-Eluting Balloon Products Offered
Table 22. Paclitaxel Drug-Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Geographic Region (2018-2023)
Table 27. Global Paclitaxel Drug-Eluting Balloon Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Paclitaxel Drug-Eluting Balloon Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2018-2023)
Table 31. Global Paclitaxel Drug-Eluting Balloon Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 34. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 35. Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 37. Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 38. Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 39. APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2018-2023) & (K Units)
Table 40. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2018-2023)
Table 41. APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2018-2023)
Table 43. APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 44. APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 45. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 46. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 47. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 49. Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 50. Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Paclitaxel Drug-Eluting Balloon
Table 58. Key Market Challenges & Risks of Paclitaxel Drug-Eluting Balloon
Table 59. Key Industry Trends of Paclitaxel Drug-Eluting Balloon
Table 60. Paclitaxel Drug-Eluting Balloon Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Paclitaxel Drug-Eluting Balloon Distributors List
Table 63. Paclitaxel Drug-Eluting Balloon Customer List
Table 64. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 80. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Boston Scientific Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 85. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boston Scientific Main Business
Table 87. Boston Scientific Latest Developments
Table 88. B. Braun Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 90. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Cook Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 95. Cook Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Cook Medical Main Business
Table 97. Cook Medical Latest Developments
Table 98. Cardionovum Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 100. Cardionovum Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cardionovum Main Business
Table 102. Cardionovum Latest Developments
Table 103. Aachen Resonance Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 105. Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Aachen Resonance Main Business
Table 107. Aachen Resonance Latest Developments
Table 108. QT Vascular Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 110. QT Vascular Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. QT Vascular Main Business
Table 112. QT Vascular Latest Developments
Table 113. Biotronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 115. Biotronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biotronic Main Business
Table 117. Biotronic Latest Developments
Table 118. Philips Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 120. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Eurocor Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 125. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Eurocor Main Business
Table 127. Eurocor Latest Developments
Table 128. Yinyi Biotech Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 129. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 130. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Yinyi Biotech Main Business
Table 132. Yinyi Biotech Latest Developments
Table 133. Lepu Medical Technology Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 134. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 135. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Lepu Medical Technology Main Business
Table 137. Lepu Medical Technology Latest Developments
Table 1. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Paclitaxel Drug-Eluting Balloon Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Balloon-Only Coating
Table 4. Major Players of Drug-Coated Balloon
Table 5. Global Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 6. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Table 7. Global Paclitaxel Drug-Eluting Balloon Revenue by Type (2018-2023) & ($ million)
Table 8. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2018-2023)
Table 9. Global Paclitaxel Drug-Eluting Balloon Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 11. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Table 12. Global Paclitaxel Drug-Eluting Balloon Revenue by Application (2018-2023)
Table 13. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application (2018-2023)
Table 14. Global Paclitaxel Drug-Eluting Balloon Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Paclitaxel Drug-Eluting Balloon Sales by Company (2018-2023) & (K Units)
Table 16. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company (2018-2023)
Table 17. Global Paclitaxel Drug-Eluting Balloon Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company (2018-2023)
Table 19. Global Paclitaxel Drug-Eluting Balloon Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Paclitaxel Drug-Eluting Balloon Producing Area Distribution and Sales Area
Table 21. Players Paclitaxel Drug-Eluting Balloon Products Offered
Table 22. Paclitaxel Drug-Eluting Balloon Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Paclitaxel Drug-Eluting Balloon Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Geographic Region (2018-2023)
Table 27. Global Paclitaxel Drug-Eluting Balloon Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Paclitaxel Drug-Eluting Balloon Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Country/Region (2018-2023)
Table 31. Global Paclitaxel Drug-Eluting Balloon Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 34. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 35. Americas Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 37. Americas Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 38. Americas Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 39. APAC Paclitaxel Drug-Eluting Balloon Sales by Region (2018-2023) & (K Units)
Table 40. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region (2018-2023)
Table 41. APAC Paclitaxel Drug-Eluting Balloon Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Region (2018-2023)
Table 43. APAC Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 44. APAC Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 45. Europe Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 46. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 47. Europe Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 49. Europe Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 50. Europe Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Paclitaxel Drug-Eluting Balloon
Table 58. Key Market Challenges & Risks of Paclitaxel Drug-Eluting Balloon
Table 59. Key Industry Trends of Paclitaxel Drug-Eluting Balloon
Table 60. Paclitaxel Drug-Eluting Balloon Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Paclitaxel Drug-Eluting Balloon Distributors List
Table 63. Paclitaxel Drug-Eluting Balloon Customer List
Table 64. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Paclitaxel Drug-Eluting Balloon Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Paclitaxel Drug-Eluting Balloon Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Paclitaxel Drug-Eluting Balloon Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Paclitaxel Drug-Eluting Balloon Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Medtronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 79. Medtronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 80. Medtronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Medtronic Main Business
Table 82. Medtronic Latest Developments
Table 83. Boston Scientific Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 84. Boston Scientific Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 85. Boston Scientific Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boston Scientific Main Business
Table 87. Boston Scientific Latest Developments
Table 88. B. Braun Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 90. B. Braun Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Cook Medical Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 94. Cook Medical Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 95. Cook Medical Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Cook Medical Main Business
Table 97. Cook Medical Latest Developments
Table 98. Cardionovum Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 99. Cardionovum Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 100. Cardionovum Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Cardionovum Main Business
Table 102. Cardionovum Latest Developments
Table 103. Aachen Resonance Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 104. Aachen Resonance Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 105. Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Aachen Resonance Main Business
Table 107. Aachen Resonance Latest Developments
Table 108. QT Vascular Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 109. QT Vascular Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 110. QT Vascular Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. QT Vascular Main Business
Table 112. QT Vascular Latest Developments
Table 113. Biotronic Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 114. Biotronic Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 115. Biotronic Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Biotronic Main Business
Table 117. Biotronic Latest Developments
Table 118. Philips Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 119. Philips Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 120. Philips Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Philips Main Business
Table 122. Philips Latest Developments
Table 123. Eurocor Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 124. Eurocor Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 125. Eurocor Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Eurocor Main Business
Table 127. Eurocor Latest Developments
Table 128. Yinyi Biotech Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 129. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 130. Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Yinyi Biotech Main Business
Table 132. Yinyi Biotech Latest Developments
Table 133. Lepu Medical Technology Basic Information, Paclitaxel Drug-Eluting Balloon Manufacturing Base, Sales Area and Its Competitors
Table 134. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product Portfolios and Specifications
Table 135. Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Lepu Medical Technology Main Business
Table 137. Lepu Medical Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Paclitaxel Drug-Eluting Balloon
Figure 2. Paclitaxel Drug-Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Drug-Eluting Balloon Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Paclitaxel Drug-Eluting Balloon Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Paclitaxel Drug-Eluting Balloon Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Balloon-Only Coating
Figure 10. Product Picture of Drug-Coated Balloon
Figure 11. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type in 2022
Figure 12. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2018-2023)
Figure 13. Paclitaxel Drug-Eluting Balloon Consumed in Peripheral Artery Disease
Figure 14. Global Paclitaxel Drug-Eluting Balloon Market: Peripheral Artery Disease (2018-2023) & (K Units)
Figure 15. Paclitaxel Drug-Eluting Balloon Consumed in Coronary Artery Disease
Figure 16. Global Paclitaxel Drug-Eluting Balloon Market: Coronary Artery Disease (2018-2023) & (K Units)
Figure 17. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2022)
Figure 18. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application in 2022
Figure 19. Paclitaxel Drug-Eluting Balloon Sales Market by Company in 2022 (K Units)
Figure 20. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company in 2022
Figure 21. Paclitaxel Drug-Eluting Balloon Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company in 2022
Figure 23. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 26. Americas Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 27. APAC Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 28. APAC Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 29. Europe Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 30. Europe Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 33. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 34. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 35. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 36. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 37. United States Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region in 2022
Figure 42. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Regions in 2022
Figure 43. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 44. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 45. China Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 53. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 54. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 55. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 56. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 65. Egypt Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2022
Figure 71. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
Figure 72. Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
Figure 73. Channels of Distribution
Figure 74. Global Paclitaxel Drug-Eluting Balloon Sales Market Forecast by Region (2024-2029)
Figure 75. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Paclitaxel Drug-Eluting Balloon
Figure 2. Paclitaxel Drug-Eluting Balloon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Drug-Eluting Balloon Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Paclitaxel Drug-Eluting Balloon Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Paclitaxel Drug-Eluting Balloon Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Balloon-Only Coating
Figure 10. Product Picture of Drug-Coated Balloon
Figure 11. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Type in 2022
Figure 12. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Type (2018-2023)
Figure 13. Paclitaxel Drug-Eluting Balloon Consumed in Peripheral Artery Disease
Figure 14. Global Paclitaxel Drug-Eluting Balloon Market: Peripheral Artery Disease (2018-2023) & (K Units)
Figure 15. Paclitaxel Drug-Eluting Balloon Consumed in Coronary Artery Disease
Figure 16. Global Paclitaxel Drug-Eluting Balloon Market: Coronary Artery Disease (2018-2023) & (K Units)
Figure 17. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2022)
Figure 18. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Application in 2022
Figure 19. Paclitaxel Drug-Eluting Balloon Sales Market by Company in 2022 (K Units)
Figure 20. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Company in 2022
Figure 21. Paclitaxel Drug-Eluting Balloon Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Company in 2022
Figure 23. Global Paclitaxel Drug-Eluting Balloon Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 26. Americas Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 27. APAC Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 28. APAC Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 29. Europe Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 30. Europe Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue 2018-2023 ($ Millions)
Figure 33. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 34. Americas Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 35. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 36. Americas Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 37. United States Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Region in 2022
Figure 42. APAC Paclitaxel Drug-Eluting Balloon Revenue Market Share by Regions in 2022
Figure 43. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 44. APAC Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 45. China Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 53. Europe Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 54. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 55. Europe Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 56. Germany Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Paclitaxel Drug-Eluting Balloon Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Market Share by Application (2018-2023)
Figure 65. Egypt Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Paclitaxel Drug-Eluting Balloon Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Paclitaxel Drug-Eluting Balloon in 2022
Figure 71. Manufacturing Process Analysis of Paclitaxel Drug-Eluting Balloon
Figure 72. Industry Chain Structure of Paclitaxel Drug-Eluting Balloon
Figure 73. Channels of Distribution
Figure 74. Global Paclitaxel Drug-Eluting Balloon Sales Market Forecast by Region (2024-2029)
Figure 75. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Paclitaxel Drug-Eluting Balloon Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Paclitaxel Drug-Eluting Balloon Revenue Market Share Forecast by Application (2024-2029)
